SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-20-068951
Filing Date
2020-03-10
Accepted
2020-03-10 17:02:19
Documents
4
Effectiveness Date
2020-03-10

Document Format Files

Seq Description Document Type Size
1 S-8 d899957ds8.htm S-8 48346
2 EX-5.1 d899957dex51.htm EX-5.1 7369
3 EX-23.1 d899957dex231.htm EX-23.1 1563
4 GRAPHIC g899957g0306093356541.jpg GRAPHIC 2533
  Complete submission text file 0001193125-20-068951.txt   61925
Mailing Address 220 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 220 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 416-7700
Principia Biopharma Inc. (Filer) CIK: 0001510487 (see all company filings)

IRS No.: 263487603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-237063 | Film No.: 20702612
SIC: 2834 Pharmaceutical Preparations